Pregabalin, a novel alpha2-delta ligand for the treatment of neuropathic pain, shows evidence of a positive cognitive and psychomotor profile in healthy volunteers

I Hindmarch; J Dawson; N Stanley; M Versavel

Back

Conference presentation

Pregabalin, a novel alpha2-delta ligand for the treatment of neuropathic pain, shows evidence of a positive cognitive and psychomotor profile in healthy volunteers

I Hindmarch, J Dawson, N Stanley and M Versavel

ANNALS OF THE RHEUMATIC DISEASES, Vol.62, pp.308-309

Annual European Congress of Rheumatology (LISBON, PORTUGAL, 18/06/2003)

01/07/2003

Abstract

Science & Technology

Life Sciences & Biomedicine

Rheumatology

RHEUMATOLOGY

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224551401014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

17 Record Views

Details

Title: Pregabalin, a novel alpha2-delta ligand for the treatment of neuropathic pain, shows evidence of a positive cognitive and psychomotor profile in healthy volunteers
Creators: I Hindmarch
J Dawson
N Stanley
M Versavel
Contributors: B M J PUBLISHING GROUP (Publisher)
Publication Details: ANNALS OF THE RHEUMATIC DISEASES, Vol.62, pp.308-309
Conference: Annual European Congress of Rheumatology (LISBON, PORTUGAL, 18/06/2003)
Date published: 01/07/2003
Date submitted: 17/05/2017
Identifiers: 99514140102346
Academic Unit: University of Surrey
Resource Type: Conference presentation

Pregabalin, a novel alpha2-delta ligand for the treatment of neuropathic pain, shows evidence of a positive cognitive and psychomotor profile in healthy volunteers

Abstract

Files and links (1)

Metrics

Details

Usage Policy